High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$21.7M
$21,675,987
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-03-06 | $212,083 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-01-26 | $318,596 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
Sell to Cover
2026-01-20
$1,098,343Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Sell to Cover
|
2026-01-20 | $1,098,343Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $3,792 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,300 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $144,761 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $47,609 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $160,205 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $206,700 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,514 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $215,706 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,610 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $217,088 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $21,832 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $110,248 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $290,878 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $491,537 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $492,595 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $482,207 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $813,968 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $269,257 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2026-01-09
$1,058,468Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $1,058,468Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $503,106 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $280,220 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $229,289 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $306,909 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $382,823 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $699,623 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $781,903 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $480,281 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $598,091 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $245,593 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $293,222 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $135,796 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $15,931 | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$2,602,307Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,602,307Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$2,433,641Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,433,641Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$2,132,197Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $2,132,197Large | S | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
Taub Rebecca
• Director
10b5-1 Sell
2025-12-10
$1,709,826Large
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $1,709,826Large | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $569,822 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $111,078 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $267,335 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2025-12-10 | $294,670 | M | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $202,418 | S | Form 4 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $268,949 | S | Form 4 |